PAXLOVID nirmatrelvir 150 mg tablet and ritonavir 100 mg tablet blister composite pack (377572)

ARTG ID 377572

ARTG Name

PAXLOVID nirmatrelvir 150 mg tablet and ritonavir 100 mg tablet blister composite pack

Product name

PAXLOVID nirmatrelvir 150 mg tablet and ritonavir 100 mg tablet blister composite pack

ARTG Date

20 January 2022

Registration Type

Medicine

Therapeutic good type

M

Ingredients

nirmatrelvir

ritonavir

Licence category

REP

Licence status

A

Summary

Product information

Consumer medicine information

Related information

18 January 2022

Section 14 consent

Pfizer Australia Pty Ltd, from CON-908, PAXLOVID nirmatrelvir 150 mg tablet and ritonavir 100 mg tablet blister composite pack

Approved for Import and supply while noncompliant with standards. The consent is effective for all batches released for supply from 18 January 2022 until 18 January 2024.
20 April 2022

Section 14 consent

Pfizer Australia Pty Ltd, from CON-925, PAXLOVID nirmatrelvir 150 mg tablet and ritonavir 100 mg tablet blister composite pack

Approved for Import and supply while noncompliant with standards. The consent is effective for all batches released for supply from the 20 April 2022 until 18 January 2024.